Novel drug resistant gene of Klebsiella pneumoniae
A technology of drug-resistant strains and amino acids, applied in antibacterial drugs, genetic engineering, plant genetic improvement, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] Example 1 Discovery of New Resistance Gene KPC-15
[0026] 1. Materials and methods
[0027] 1. Materials
[0028] VITEK2 from bioMerieux, France; Bacterial identification card; VITEK2GN Test kit; Bacterial susceptibility card; prime); TakaRa’s miniBEST plasmid purification Kit; high-fidelity polymerase, and other reagents are commercially available.
[0029] 2. Method
[0030] 2.1 Isolation and identification of Klebsiella pneumoniae KP1241 strain
[0031] Transfer the positive strains from the blood culture of the cardiothoracic surgery patients in Taizhou Municipal Hospital to the blood plate for isolation and culture, and culture them in an incubator containing 5% CO2 at 35°C for 16-18 hours, and then use the VITEK2 of bioMerieux to isolate the isolated monoclonal strains according to the operating procedures. Bacteria identification and drug susceptibility analysis system and drug sensitivity plate agar diffusion method (supplement drug sensitivity paper sheet) w...
Embodiment 2
[0068] Example 2 Bacterial plasmid transduction experiment and drug resistance detection
[0069] 1. Materials and methods
[0070] 1. Materials
[0071] Klebsiella pneumoniae (accession number KP1241); wild-type E. coli J53.
[0072] 2. Methods and results
[0073] Klebsiella pneumoniae KP1241 and wild-type E.coli J53AzR (resistance to sodium azide) were used as donor bacteria and recipient bacteria respectively, and 0.5ml of each in the logarithmic growth phase was added to 4ml of fresh LB Incubate overnight in broth. The zygotes were screened on trypan soy agar (TSA) plates containing sodium azide (300mg / L) and ciprofloxacin (0.03mg / L), and incubated at 35°C for 18-24 hours. The screened zygotes were analyzed for their sensitivity to drugs with the VITEK2 bacterial identification and drug sensitivity analysis system of bioMerieux and the drug sensitivity plate agar diffusion method (supplementary drug sensitivity paper). The results are shown in Table 2:
[0074] Table...
Embodiment 3
[0078] The construction of embodiment 3 constitutive KPC-15 gene expression bacteria
[0079] 1. Materials and methods
[0080] 1. Materials
[0081] E.coli JM109; pMD18T carrier of TaKaRa Company; pBR322 carrier; restriction endonuclease Pst I and EcoR I of TaKaRa Company; agarose gel recovery kit of Tiangen Biochemical Technology (Beijing) Co., Ltd.; T4 DNA ligase.
[0082] 2. Method
[0083] 2.1 Construction of constitutive KPC-15 gene expression strain E.coli JM109 (pET32a-KPC-15)
[0084] The PCR product in Example 1 was ligated with the pMD18T vector, and the ligated product was added to 100 μl JM109 competent for transformation, cultured on a plate containing IPTG, x-gal, and Amp, and sequenced to verify that the gene sequence and its gene insertion direction were correct. Then the KPC-15 gene was cloned into the pET32a vector to obtain the pET32a-KPC-15 plasmid containing the KPC-15 gene. The recombinant plasmid was transformed into competent E.coli JM109 cells, c...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
